Author: Kevin Cahill

Experimental Pathology Laboratories, Aclairo Pharmaceutical Development Group, and Expedient Solutions International Form Strategic Alliance to Enhance Pathology and Regulatory Consulting Services to the Greater China Region

Experimental Pathology Laboratories, Inc. (EPL), Aclairo Pharmaceutical Development Group, Inc. (Alcairo), and Dr. Ada H.C. Kung with Expedient Solutions International (ESI) announce a new strategic alliance to enhance Preclinical Pathology and Regulatory Consulting Services to the Greater China pharmaceutical and biotechnology industry.  This alliance is targeted to expand and enhance EPL, Aclairo, and ESI’s capabilities […]

PathologySafety AssessmentToxicology

Dr. Paul Snyder Elected as President of Society of Toxicologic Pathology (STP)

Experimental Pathology Laboratories, Inc. (EPL®) is proud to announce that Dr. Paul Snyder has been elected as President of the Society of Toxicologic Pathology (STP).  He will begin serving on the Executive Committee starting in June 2017 along with Mark J. Hoenerhoff (NIEHS) and Stacey Fossey (AbbVie) who will serve four-year terms as Councilors.  Dr. […]

Pathology

EPL to Exhibit at the 56th Annual Society of Toxicology (SOT) Meeting

EPL will once again be exhibiting at ToxExpo™ in Baltimore from March 13-15, 2017.  If you are attending the 56th Annual Society of Toxicology Meeting, please visit our teams from EPL and Aclairo; we will be exhibiting in Booth #2332. Please stop by and visit EPL if you are in Baltimore!  For more information about the SOT, […]

DiscoveryPathologySafety AssessmentToxicology

EPL Names New Vice President

EPL is pleased to announce that Dr. Tom Steinbach will serve as Vice President of EPL, Inc.  As EPL Vice President, Dr. Steinbach will work with EPL’s President and other corporate officers to formulate and implement EPL’s strategic goals.  He will continue to oversee all operations in EPL’s North Carolina facility and manage EPL’s largest […]

PathologyToxicology

Stereology: Turn Up the Volume!

Stereology is a tool for obtaining unbiased estimates of object numbers and/or sizes within three-dimensional regions of interest.  For biological samples, quantitative measurements are potentially more objective and accurate when compared to traditional semi-quantitative grading of findings by pathologists (i.e., scoring of morphologic changes as minimal, mild, moderate, or severe).  Although both approaches require high […]

Pathology

The Benefits of Entrusting Your Histopathology Services to EPL

Companies who outsource the histopathology component of their valuable studies need to know that the work will be performed to the highest quality standards, on time, and at competitive prices.  Although claims of quality are easily made, true quality can be a difficult metric to gauge.  So let’s look at the evidence. Unlike its few […]

Biological TestingDiscoveryHistologyPathologySafety AssessmentToxicology

EPL Announces New President

EPL is pleased to announce the promotion of Dr. Kathleen Funk to President of EPL on June 1, 2016.  Dr. Funk has served as the Chief Operating Officer since 2014.  Dr. Funk is a graduate of the Virginia-Maryland Regional College of Veterinary Medicine and also holds a PhD in Comparative Pathology from the University of […]

HistologyPathologySafety AssessmentToxicology

EPL and Histion Form Strategic Alliance to Enhance Medical Device and Biomaterial Testing

EPL announces a newly formed strategic alliance with Histion, an Everett, Washington based preclinical laboratory specializing in GLP-compliant routine and specialty histology and evaluation services.  This alliance is specifically targeted to expand and enhance EPL’s and Histion’s capabilities to an ever expanding area of medical device and novel biomaterial testing.  Although Histion specializes in processing […]

Biological TestingDiscoveryHistologyPathologySafety Assessment

EPL, Inc. Opens a Northeast Office in Collegeville, Pennsylvania

Experimental Pathology Laboratories, Inc. (EPL®) established EPL Northeast on February 8, 2016. This office is headed by Dr. Heath Thomas who was formerly Vice President of Safety Assessment at GlaxoSmithKline. The Northeast office is located outside of Philadelphia at 125 Chinaberry Lane, Collegeville, PA. With this location, Dr. Thomas will be able to provide local […]

DiscoveryPathologySafety AssessmentToxicology

Meet Aclairo Pharmaceutical Development Group

Imagine a group of great scientists and all around nice folks who worked with another group for years in dovetailed projects for their clients. It does not take much imagination to wonder why these folks would want to be in one happy group together.  On January 1, 2016, EPL, Inc.  acquired Aclairo PDG, Inc. as […]

Clinical Pharmacology & ModelingDiscoverySafety AssessmentToxicology